Pharmacotherapy for pediatric chronic intestinal pseudo‐obstruction: Nationwide survey in Japan

• Published in: Pediatrics international Vol. 59; no. 4; pp. 467 - 472
• Main Authors: Hashizume, Naoki, Yagi, Minoru, Ushijima, Kosuke, Seki, Yoshitaka, Fukahori, Suguru, Muto, Mitsuru, Matsufuji, Hiroshi, Taguchi, Tomoaki
• Format: Journal Article
• Language: English
• Published: Australia Blackwell Publishing Ltd 01.04.2017
• Subjects: Adolescent; Adult; Benzamides - therapeutic use; Child; Child, Preschool; Chronic Disease; chronic intestinal pseudo‐obstruction; Clinical trials; Drug therapy; Drug Therapy, Combination; Drug Utilization - statistics & numerical data; Female; Gastrointestinal Agents - therapeutic use; Health Care Surveys; Herbal medicine; Humans; Infant; Infant, Newborn; Intestinal Pseudo-Obstruction - drug therapy; Intestine; Japan; Laxatives; Laxatives - therapeutic use; Male; Medicine, Kampo - utilization; Morpholines - therapeutic use; nationwide survey; Pediatrics; Peristalsis; pharmacotherapy; Phytotherapy - statistics & numerical data; Phytotherapy - utilization; Practice Patterns, Physicians' - statistics & numerical data; Probiotics; Probiotics - therapeutic use; Young Adult; Japan; chronic intestinal pseudo-obstruction; nationwide survey; pharmacotherapy; child
• ISSN: 1328-8067; 1442-200X
• DOI: 10.1111/ped.13201

Background Chronic intestinal pseudo‐obstruction (CIPO) is a rare disabling and life‐threatening disorder characterized by severe impairment of gastrointestinal peristalsis. While a number of pharmacotherapeutics have been developed, only a few trials have been carried out for improvement of the pathological condition of CIPO patients. This report describes the results of a nationwide survey on the pharmacotherapy used in pediatric CIPO in Japan. Methods In 2012, a nationwide survey was conducted to identify the clinical presentation of CIPO in Japan. Information was gathered on pharmacotherapy. Four categories were created for medicines used in pharmacotherapy: “probiotics”, “Japanese herbal medicines (Kampo medicines)”, “laxatives”, and “prokinetics”. Results Ninety‐two responses were collected from 47 facilities. Of the 62 patients who met the diagnostic criteria, 52 were treated with medications, while the remaining 10 were not. Thirty‐four patients were given a total of 49 probiotics; 39 were treated with a total of 50 Kampo medicines; 20 were treated with a total of 28 laxatives; and 26 were given a total of 30 prokinetics, 70% of whom were treated specifically with mosapride. Conclusion Traditional Japanese medicines such as Kampo medicines and mosapride are often used to treat CIPO in Japan. Two combinations, that is, probiotics and Kampo medicines; and Kampo medicines and prokinetics, were often used for pediatric CIPO in Japan.